Lenz Therapeutics Inc (LENZ)

12:27 PM

LENZ Therapeutics Reports Preliminary Q4 2025 Results, Highlights VIZZ Launch - VisionMonday.com

12:27 PM

Jan 08, 2026

Can LENZ Therapeutics Inc. stock reach $100 price targetJuly 2025 Patterns & Real-Time Buy Signal Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

How sustainable is LENZ Therapeutics Inc. stock dividend payoutJuly 2025 Opening Moves & Long Hold Capital Preservation Tips - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Will LENZ Therapeutics Inc. stock see insider buyingJuly 2025 Short Interest & Accurate Intraday Trading Signals - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Why LENZ Therapeutics Inc. stock is recommended by analystsTrade Risk Assessment & Community Verified Trade Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Why LENZ Therapeutics Inc. stock could outperform in 2025Analyst Upgrade & Risk Controlled Stock Pick Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Why LENZ Therapeutics Inc. stock is popular among millennialsJuly 2025 Selloffs & Daily Oversold Bounce Ideas - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Analysts Expect Breakeven For LENZ Therapeutics, Inc. (NASDAQ:LENZ) Before Long - Yahoo Finance

Jan 08, 2026

Jan 07, 2026

LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates - The Manila Times

Jan 07, 2026

Jan 07, 2026

LENZ Therapeutics Reports Strong Initial Sales and Prescription Volume for VIZZ™ after Launch for Presbyopia Treatment - Quiver Quantitative

Jan 07, 2026

Jan 06, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ ... - Bluefield Daily Telegraph

Jan 06, 2026

Jan 06, 2026

Page not foundFactor Thisâ„¢ - FinancialContent

Jan 06, 2026

Jan 06, 2026

Lenz, Lunatus announce exclusive partnership for VIZZ in Middle East - Yahoo Finance

Jan 06, 2026

Jan 06, 2026

LENZ Therapeutics and Lunatus Announce Exclusive Commercialization Partnership for VIZZ in the Middle East - MarketScreener

Jan 06, 2026

Jan 06, 2026

LENZ Therapeutics and Lunatus Ink Exclusive Commercialization Partnership for VIZZ in Middle East - VisionMonday.com

Jan 06, 2026

Jan 05, 2026

Lenz Therapeutics and Lunatus announce partnership for Vizz(TM) - marketscreener.com

Jan 05, 2026

Jan 05, 2026

LENZ Therapeutics and Lunatus Announce Exclusive Commercialization Partnership for VIZZ™ in the Middle East - The Manila Times

Jan 05, 2026

Jan 05, 2026

FDA-approved presbyopia eye drop VIZZ to reach Middle East - Stock Titan

Jan 05, 2026

Jan 02, 2026

LENZ Therapeutics responds to FDA adverse event report - MSN

Jan 02, 2026

Jan 02, 2026

LENZ Therapeutics (NASDAQ:LENZ) Hits New 1-Year LowWhat's Next? - MarketBeat

Jan 02, 2026

Jan 01, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc.LENZ - PR Newswire

Jan 01, 2026

Jan 01, 2026

Is LENZ Therapeutics Inc a good long term investmentConsumer Goods Stocks & Free Stay Informed With Forecasts - earlytimes.in

Jan 01, 2026

Dec 31, 2025

Aug Mood: Why LENZ Therapeutics Inc stock is recommended by analystsQuarterly Profit Summary & Expert Approved Trade Ideas - moha.gov.vn

Dec 31, 2025

Dec 27, 2025

LENZ Therapeutics (LENZ) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 27, 2025

Dec 23, 2025

LENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 5.1%Time to Sell? - MarketBeat

Dec 23, 2025

Dec 22, 2025

Lenz plunges after adverse event report on eye therapy - MSN

Dec 22, 2025

Dec 20, 2025

How LENZ Therapeutics Inc. stock compares to industry benchmarksPortfolio Growth Summary & Growth Focused Investment Plans - Улправда

Dec 20, 2025

Dec 19, 2025

Is LENZ Therapeutics Inc. stock trading near support levels2025 Institutional Moves & Technical Pattern Recognition Alerts - ulpravda.ru

Dec 19, 2025

Dec 18, 2025

LENZ Therapeutics Stock Plummets 42% With 10-Day Losing Streak - Trefis

Dec 18, 2025

Dec 17, 2025

LENZ Therapeutics (NASDAQ:LENZ) Shares Up 5%What's Next? - MarketBeat

Dec 17, 2025

Dec 17, 2025

LENZ Therapeutics: Was That A Market Overreaction? (NASDAQ:LENZ) - Seeking Alpha

Dec 17, 2025

Dec 17, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Dec 17, 2025

Dec 17, 2025

LENZ Therapeutics Stock 9-Day Losing Spree: Stock Falls 40% - Trefis

Dec 17, 2025

Dec 16, 2025

LENZ Therapeutics Currently Down Nine Consecutive Days, On Pace for Longest Losing Streak Since March 2022 -- Data Talk - 富途牛牛

Dec 16, 2025

Dec 16, 2025

8-Day Sell-Off Sends LENZ Therapeutics Stock Down 39% - Trefis

Dec 16, 2025

Dec 15, 2025

LENZ Therapeutics (NASDAQ:LENZ) Shares Gap UpHere's What Happened - MarketBeat

Dec 15, 2025

Dec 13, 2025

LENZ Therapeutics (NASDAQ:LENZ) Sees Large Volume IncreaseShould You Buy? - MarketBeat

Dec 13, 2025

Dec 12, 2025

LENZ Therapeutics Responds to FDA Adverse Event Report - TipRanks

Dec 12, 2025

Dec 12, 2025

LENZ Therapeutics Addresses Adverse Event Report - TradingView — Track All Markets

Dec 12, 2025

Dec 12, 2025

Lenz Therapeutics (Nasdaq: LENZ) provides update on VIZZ safety data report - Stock Titan

Dec 12, 2025

Dec 12, 2025

ABBV Stock News: Lenz Therapeutics Faces Setback with FDA Report - GuruFocus

Dec 12, 2025

Dec 12, 2025

LENZ stock tumbles after retinal tear case surfaces in FDA database - Investing.com

Dec 12, 2025

Dec 12, 2025

LENZ stock plunges after adverse event report (LENZ:NASDAQ) - Seeking Alpha

Dec 12, 2025

Dec 10, 2025

Stempoint Capital LP Buys Shares of 183,912 LENZ Therapeutics, Inc. $LENZ - MarketBeat

Dec 10, 2025

Dec 10, 2025

No Need For Reading Glasses? Vizz Eye Drop That Improves Near Vision Has FDA Nod - MSN

Dec 10, 2025